JNJ
Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
28.54
PEG Ratio
-
Dividend Yield
-
Gross Margin
71.49%
Net Margin
21.76%
Revenue CAGR 3Y
4.82%
ROE
25.79%
ROA
10.42%
Buyback Yield
-0.25%
Current Ratio
1.03
Magic Earn Yield
-
Altman Z-Score
-
Fair Value River
Score
Valuation 43
Profitability 52
Growth 16
Health 34
Yield 0